Death rates from opioid-involved drug use among Black, Latine, and Indigenous Americans are increasing more quickly than death rates for White people despite comparable rates of opioid use across these groups [1,2,3]. Drivers of these escalating mortality rates are steeped in structural racism, including inequitable distribution of medication for addiction treatment and limited access to quality culturally informed treatment programs and harm reduction services [3,4,5].
